Endothelial glycocalyx damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress

Shock

Volumn 29, Issue 5, 2008, Pages 572-576

  Marechal, Xavier ^a,b   Favory, Raphael ^a   Joulin, Olivier ^a   Montaigne, David ^a,b   Hassoun, Sidi ^a,b   Decoster, Brigitte ^a,b   Zerimech, Farid ^c   Neviere, Remi ^a,b  

^a IMPECS IMPact de l Environnement Chimique sur la Santé humaine   (France)

^b UNIV LILLE   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Glycocalyx; Intravital microscopy; LPS; Microcirculation; Oxidative stress; Rats

Indexed keywords

ACTIVATED PROTEIN C; CATECHOLAMINE; DIHYDRORHODAMINE 123; HYALURONIC ACID; LIPOPOLYSACCHARIDE; MALONALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CAPILLARY FLOW; CONTROLLED STUDY; ENDOTHELIUM INJURY; ENDOTOXEMIA; GLYCOCALYX; HEART MUSCLE; INTESTINE MUSCLE; MICROCIRCULATION; NONHUMAN; OXIDATIVE STRESS; RAT; SEPSIS; SEPTIC SHOCK;

EID: 42149084524     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318157e926     Document Type: Article

References (30)

1. Angus DC, Wax RS: Epidemiology of sepsis: an update. Crit Care Med 29:S109-S116, 2001.
2. Annane D, Bellissant E, Cavaillon JM: Septic shock. Lancet 365:63-78, 2005.
3. Neviere R, Mathieu D, Chagnon JL, Lebleu N, Millien JP, Wattel F: Skeletal muscle microvascular blood flow and oxygen transport in patients with severe sepsis. Am J Respir Crit Care Med 153:191-195, 1996.
4. Ellis CG, Jagger J, Sharpe M: The microcirculation as a functional system. Crit Care Suppl 4:S3-S8, 2005.
5. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 348:138-150, 2003.
6. Pries AR, Kuebler WM: Normal endothelium. Handb Exp Pharmacol 176:1-40, 2006.
7. Taylor KR, Gallo RL: Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J 20:9-22, 2006.
8. Vink H, Duling BR: Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circ Res 79:581-589, 1996.
9. Rubio-Gayosso I, Platts SH, Duling BR: Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury. Am J Physiol 290:H2247-H2256, 2006.
10. Nieuwdorp M, Mooij HL, Kroon J, Atasever B, Spaan JA, Ince C, Holleman F, Diamant M, Heine RJ, Hoekstra JB, et al.: Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes 55:1127-1132, 2006.
11. Constantinescu AA, Vink H, Spaan JA: Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface. Arterioscler Thromb Vasc Biol 23:1541-1547, 2003.
12. Abraham E, Laterre PF, Garg R, Levy H, Talwar D, Trzaskoma BL, Francois B, Guy JS, Bruckmann M, Rea-Neto A, et al., Administration of Drotrecogin Alfa (Activated) in Early Stage Severe Sepsis (ADDRESS) Study Group: Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 353:1332-1341, 2005.
13. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, et al., Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699-709, 2001.
14. Hoffmann JN, Vollmar B, Laschke MW, Inthorn D, Fertmann J, Schildberg FW, Menger MD: Microhemodynamic and cellular mechanisms of activated protein C action during endotoxemia. Crit Care Med 32:1011-1017, 2004.
15. Iba T, Kidokoro A, Fukunaga M, Nagakari K, Shirahama A, Ida Y: Activated protein C improves the visceral microcirculation by attenuating the leukocyte-endothelial interaction in a rat lipopolysaccharide model. Crit Care Med 33:368-372, 2005.
16. Han JY, Miura S, Akiba Y, Higuchi H, Kato S, Suzuki H, Yokoyama H, Ishii H: Chronic ethanol consumption exacerbates microcirculatory damage in rat mesentery after reperfusion. Am J Physiol 280:G939-G948, 2001.
17. Pries AR, Secomb TW, Gaehtgens P: The endothelial surface layer. Pflugers Arch 440:653-666, 2000.
18. Tarbell JM, Pahakis MY: Mechanotransduction and the glycocalyx. J Intern Med 259:339-350, 2006.
19. Gouverneur M, Berg B, Nieuwdorp M, Stroes E, Vink H: Vasculoprotective properties of the endothelial glycocalyx: effects of fluid shear stress. J Intern Med 259:393-400, 2006.
20. Pries AR, Secomb TW, Jacobs H, Sperandio M, Osterloh K, Gaehtgens P: Microvascular blood flow resistance: role of endothelial surface layer. Am J Physiol 273:H2272-H2279, 1997.
21. Pries AR, Schonfeld D, Gaehtgens P, Kiani MF, Cokelet GR: Diameter variability and microvascular flow resistance. Am J Physiol 272:H2716-H2725, 1997.
22. Vogel J, Sperandio M, Pries AR, Linderkamp O, Gaehtgens P, Kuschinsky W: Influence of the endothelial glycocalyx on cerebral blood flow in mice. J Cereb Blood Flow Metab 20:1571-1578, 2000.
23. Secomb TW, Hsu R, Pries AR: A model for red blood cell motion in glycocalyx-lined capillaries. Am J Physiol 274:H1016-H1022, 1998.
24. Damiano ER: The effect of the endothelial-cell glycocalyx on the motion of red blood cells through capillaries. Microvasc Res 55:77-91, 1998.
25. Cabrales P, Salazar Vazquez BY, Tsai AG, Intaglietta M. Microvascular and capillary perfusion following glycocalyx degradation. J Appl Physiol 102:fp 2251-2259, 2007.
26. Favory R, Lancel S, Marechal X, Tissier S, Neviere RL: Cardiovascular protective role for activated protein C during endotoxemia in rats. Intensive Care Med 32:899-905, 2006.
27. Wiel E, Costecalde ME, Lebuffe G, Corseaux D, Jude B, Bordet R, Tavernier B, Vallet B: Activated protein C increases sensitivity to vasoconstriction in rabbit Escherichia coli endotoxin-induced shock. Crit Care 10:R47, 2006.
28. Monnet X, Lamia B, Anguel N, Richard C, Bonmarchand G, Teboul JL: Rapid and beneficial hemodynamic effects of activated protein C in septic shock patients. Intensive Care Med 31:1573-1576, 2005.
29. Yamaji K, Wang Y, Liu Y, Abeyama K, Hashiguchi T, Uchimura T, Krishna Biswas K, Iwamoto H, Maruyama I: Activated protein C, a natural anticoagulant protein, has antioxidant properties and inhibits lipid peroxidation and advanced glycation end products formation. Thromb Res 115:319-325, 2005.
30. Dillon JP, Laing AJ, Cahill RA, O'Brien GC, Street JT, Wang JH, Mc Guinness A, Redmond HP: Activated protein C attenuates acute ischaemia reperfusion injury in skeletal muscle. J Orthop Res 23:1454-1459, 2005.